Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

Soliris® Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
December 4, 2007
HTML PDF
Alexion Pharmaceuticals to Present Data on Soliris® (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
November 9, 2007
HTML PDF
Alexion to Present at Investor Conferences
November 6, 2007
HTML PDF
Alexion Reports Third Quarter 2007 Results
October 25, 2007
HTML PDF
Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
October 11, 2007
HTML PDF
Alexion to Present at Bear Stearns Healthcare Conference
September 4, 2007
HTML PDF
PNH Patients Treated with Soliris™ Experienced Dramatic Reduction in Blood Clots During Clinical Trials
August 20, 2007
HTML PDF
Alexion Reports Second Quarter 2007 Results
July 25, 2007
HTML PDF
Alexion to Present At Cowen and Company 7th Annual Global Health Care Conference
November 3, 2006
HTML PDF
Alexion Pharmaceuticals Reports Third Quarter 2006 Results
November 1, 2006
HTML PDF